Nitric oxide and oxidative stress in atherosclerotic renovascular hypertension: Effect of endovascular treatment

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 7, 2003, Pages 887-892

  Parildar, Mustafa ^a   Parildar, Zuhal ^a   Oran, Ismail ^a   Kabaroglu, Ceyda ^a   Memis, Ahmet ^a   Bayindir, Oya ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CATALASE; CREATININE; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD PRESSURE; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERVENTIONAL RADIOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

EID: 0038165100     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000083841.97061.12     Document Type: Article

References (46)

1. Excerpts from the 1993 USRDS Annual Data Report. Am J Kidney Dis 1993; 22(suppl 2):1-118.
2. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994; 24:622-629.
3. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344:431-442.
4. Van Bockel JH, Van Schilfgaarde R, Felthuis W, Hermans J, Van Brummelen P, Terpstra JL. Surgical treatment of renovascular hypertension caused by arteriosclerosis. I. Influence of preoperative factors on blood pressure control early and late after reconstructive surgery. Surgery 1987; 101:698-705.
5. Weibull H, Bergqvist, Jendteg S, et al. Clinical outcome and health care costs in renal revascularization: percutaneous transluminal renal angioplasty versus reconstructive surgery. Br J Surg 1991; 78:620-624.
6. Shanley PF. The pathology of chronic renal ischemia. Semin Nephrol 1996; 16:21-32.
7. Kellerman PS. Cellular and metabolic consequences of chronic ischemia on renal function. Semin Nephrol 1996; 16: 33-42.
8. Lerman LO, Nath KA, Rodriquez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37:541-546.
9. Nakae D, Kobayashi Y, Akai H, et al. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 1997; 57:1281-1287.
10. Fraga G, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A 1990; 87:4533-4537.
11. Irani K. Oxidant signaling in vascular cell growth, death and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87:179-183.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
13. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995; 41:892-896.
14. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995; 41:904-907.
15. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Granjean P. Plasma malondialdehyde as a biomarker for oxidative stress: reference intervals and effects of life-style factors. Clin Chem 1997; 43:1209-1214.
16. Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:497-500.
17. Goth L. A simple method for determination of serum catalase activity and reference ranges. Clin Chim Acta 1991; 196:143-152.
18. Martin LG, Rundback JH, Sacks D, et al. Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol 2002; 13: 1069-1083.
19. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183.
20. Kaatee R, Beek FJ, Verschuyl EJ, et al. Atherosclerotic renal artery stenosis: ostial or truncal? Radiology 1996; 199: 637-640.
21. Wilson SH, Berger PB, Mathew V, et al. Immediate and late outcomes after direct stent implantation without balloon predilation. J Am Coll Cardiol 2000; 35:937-943.
22. Fiala LA, Jackson MR, Gillespie DL, O'Donnel S, Lukens M, Gorman P. Primary stenting of atherosclerotic renal artery stenosis. Ann Vasc Surg 1998; 12:128-133.
23. Welch WJ. The pathophysiology of renin release in renovascular hypertension. Semin Nephrol 2000; 20:394-401.
24. Romero JC, Reckelhoff JF. State-of-the-art lecture: role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999; 34:943-949.
25. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contributions to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-1923.
26. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346:1954-1962.
27. Inoue N, Ramasamy S, Fukuai T, Nerem RM, Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 1996; 79:32-37.
28. Schnackenberg CG, Wilkins FC, Granger JP. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension 1995; 26:1024-1029.
29. Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 1999; 140: 2183-2190.
30. De La Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Nacle I, Sanchez de la Cuesta F. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans. Eur J Clin Pharmacol 2002; 57:775-780.
31. Hutcheson IR, Griffith TM, Pitman MR, et al. Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 1999; 128:451-457.
32. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31:51-60.
33. Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999; 33: 420-424.
34. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87:840-844.
35. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-H827.
36. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide and superoxide. Am J Physiol 1995; 268:L699-L722.
37. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. In: Packer L, ed. Methods of Enzymology. San Diego: Academic Press, 1994;229-240.
38. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989; 13:859-864.
39. Casentino F, Sill JC, Katusic ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994; 23:229-235.
40. Kohno M, Horio T, Ikeda M, et al. Angiotensin II stimulates endothelin-I secretion in cultured rat mesangial cells. Kidney Int 1992; 42:860-866.
41. 2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol 1995 (Suppl 3); 26:S51-S52.
42. Huang WC, Tsai RY, Fang TC. Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats. J Hypertens 2000; 18:601-613.
43. Canzanello VJ, Millan VG, Spiegel JE, Ponce PS, Kopelman RI, Madias NE. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension 1989; 13:163-172.
44. Harden PN, MacLeod MJ, Rodger RSC, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349:1133-1136.
45. Farmer CKT, Reidy J, Kalra PA, Cook GJR, Scoble J. Individual kidney function before and after renal angioplasty. Lancet 1998; 352:288-289.
46. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216:78-85.